Equities

Why 2022 could be a year of uncertainty, and opportunity, for the FTSE 100

Robert Stephens, CFA, considers the outlook for the FTSE 100 in 2022

Futura Medical – ready to go up again

Does Futura Medical offer a solid investment opportunity for 2022?

DWF Group – making real progress

Mark Watson-Mitchell follows up on this legal and business services group after it posted its interim results.

Small cap round up featuring NWOR, SRC and SCE

Mark Watson-Mitchell updates his readers on previous company profiles and other news of interest from the exciting world of small-cap…

Can shares in Diageo and GSK continue to outperform the FTSE 100?

Robert Stephens, CFA, considers the outlook for two FTSE 100-beating stocks

The Fulham Shore – set to make more dough?

Mark Watson-Mitchell takes a look at this restauranteur after its interims and in the shadow of a potential new wave…

i3 Energy – earnings accretive acquisitions have transformed this penny stock

Mark Watson-Mitchell considers this Scottish oil and gas firm after its recent update.

STV Group – record revenues point the way

Mark Watson-Mitchell tunes in to this regional broadcaster after its recent results.

Why BP and SSE could offer income investing appeal

Robert Stephens, CFA, discusses the dividend prospects for BP and SSE.

Time to clean up with the Small Cap picks

Mark Watson-Mitchell updates his readers on previous company profiles and other news of interest from the exciting world of small-cap…